Android app on Google Play

JPMorgan Downgrades Idenix Pharmaceuticals Inc. (IDIX) to Neutral

June 21, 2013 7:13 AM EDT Send to a Friend
Get Alerts IDIX Hot Sheet
Price: $24.44 +0.08%

Rating Summary:
    2 Buy, 14 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 43 | Down: 33 | New: 14
Trade IDIX Now!
Join SI Premium – FREE
JPMorgan downgraded Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) from Overweight to Neutral with a price target of $5.00 (from $13.00).

For an analyst ratings summary and ratings history on Idenix Pharmaceuticals Inc. click here. For more ratings news on Idenix Pharmaceuticals Inc. click here.

Shares of Idenix Pharmaceuticals Inc. closed at $5.13 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Downgrades, Hot Downgrades

Related Entities

JPMorgan

Add Your Comment